Print

RBI raises India’s GDP growth forecast to 7.3 pc

The Reserve Bank of India (RBI) on Friday raised its GDP growth forecast for the Indian economy to a robust 7.3 per cent for 2025-26, up from 6.8 per cent earlier, supported by strong agricultural prospects, the continued impact of GST rate cuts, low inflation and healthy balance sheets of corporates and banks.

Addressing a press conference after the Monetary Policy Committee meeting here, RBI Governor Sanjay Malhotra said the surge in economic growth to 8.2 per cent in the second quarter of the current financial year and the decline in inflation to 1.7 per cent had created a rare “Goldilocks period” for the Indian economy.

“Looking ahead, domestic factors such as healthy agricultural prospects, continued impact of GST rationalisation, benign inflation, healthy balance sheets of corporates and financial institutions, and congenial monetary and financial conditions should continue to support economic activity. Continuing reform initiatives would further facilitate growth,” Malhotra explained.

On the external front, he said services exports are likely to remain strong, while merchandise exports face some headwinds. External uncertainties continue to pose downside risks to the outlook, while the speedy conclusion of various ongoing trade and investment negotiations presents upside potential.

“Taking all these factors into consideration, real GDP growth for 2025-26 is projected at 7.3 per cent, with Q3 at 7.0 per cent and Q4 at 6.5 per cent. Real GDP growth for Q1:2026-27 is projected at 6.7 per cent and Q2 at 6.8 per cent. The risks are evenly balanced,” the RBI Governor stated.

Malhotra pointed out that the country’s real gross domestic product (GDP) registered a six-quarter high growth of 8.2 per cent in Q2:2025-26, underpinned by resilient domestic demand amid global trade and policy uncertainties. On the supply side, real gross value added (GVA) expanded by 8.1 per cent, aided by buoyant industrial and services sectors. Economic activity during the first half of the financial year benefited from income tax and GST rationalisation, softer crude oil prices, front-loaded government capital expenditure, and facilitative monetary and financial conditions supported by benign inflation.

He further stated that high-frequency indicators suggest domestic economic activity is holding up in Q3, though some emerging signs of weakness are visible in a few leading indicators. GST rationalisation and festival-related spending supported domestic demand during October–November. Rural demand continues to remain robust, while urban demand is recovering steadily. Investment activity also remains healthy, with private investment gaining momentum on the back of expansion in non-food bank credit and high capacity utilisation.

On the supply side, agricultural growth is supported by healthy kharif crop production, higher reservoir levels and improved rabi crop sowing. Manufacturing activity continues to improve, while the services sector is maintaining a steady pace, he added.

(IANS)

RELATED ARTICLES

09/06/26 | 4:16 pm | Indian equity markets

Nifty, Sensex end higher on fag-end buying; PSU banks and financial stocks lead rally

Indian equity markets ended higher on Tuesday, supported by late buying in select sectors such as PSU banks, financial services, and automobiles, while improving global risk sentiment also aided investor confidence. The benchmark indices closed in t...

09/06/26 | 3:04 pm | Mihir Kumar

GeM Procurement from MSEs Crosses Rs 8.69 Lakh Crore; Registered Units Rise to 11.9 Lakh

The Government e Marketplace (GeM) has recorded procurement worth more than ₹8.69 lakh crore from micro and small enterprises (MSEs), while the number of registered MSEs on the platform has increased to over 11.9 lakh from 2,396 in 2016-17, accordi...

09/06/26 | 10:55 am | GDRC (Global Drug Regulators Conclave) 2026

Piyush Goyal invites global pharma firms to invest in India

Union Commerce and Industry Minister Piyush Goyal on Monday invited global pharmaceutical companies to partner with India as it advances towards innovation-led and inclusive healthcare, saying the country's pharmaceutical industry, currently valued a...